Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Minocin (Minocycline) for Injection in Healthy Adults
Clinical trial NCT02802631 · COMPLETED
Trial details
- NCT number
- NCT02802631
- Sponsor
- Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-20
- Primary completion
- 2018-02-08
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.